Related references
Note: Only part of the references are listed.Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study
Nicolas Henry et al.
FRONTIERS IN MEDICINE (2021)
Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals
Angela Liu et al.
TRANSFUSION (2021)
Validation ofPLASMICscore: an academic medical center case series (2012-present)
Harrison Moosavi et al.
TRANSFUSION (2020)
Validation of the PLASMIC score for predicting ADAMTS13 activity < 10% in patients with suspected thrombotic thrombocytopenic purpura in Alberta, Canada
Chris Wynick et al.
THROMBOSIS RESEARCH (2020)
Etiology and Outcomes of Thrombotic Microangiopathies
Guillaume Bayer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative
Vivek A. Upadhyay et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Le rapport protéinurie/créatinurie améliore nettement la discrimination SHU/PTT à l’ère des thérapies ciblées : un test simple et performant
L. Burguet et al.
Nephrologie & Therapeutique (2019)
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
M. Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine
Paul Coppo et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
Plasmic score applicability for the diagnosis of thrombotic microangiopathy associated with ADAMTS13-acquired deficiency in a developing country
Deivide Sousa Oliveira et al.
HEMATOLOGY TRANSFUSION AND CELL THERAPY (2019)
External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment
A. Li et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Validation of PLASMIC score and follow-up data in a cohort of patients with suspected microangiopathies from Southern Italy
Giovanni Luca Tiscia et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)
Validation of the PLASMIC score, a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis, in Chinese patients
Ning Tang et al.
THROMBOSIS RESEARCH (2018)
Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies
M. Scully et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Validation of the PLASMIC score at a University Medical Center
Ryan Jajosky et al.
TRANSFUSION AND APHERESIS SCIENCE (2017)
The PLASMIC score for thrombotic thrombocytopenic purpura
Matthieu Jamme et al.
LANCET HAEMATOLOGY (2017)
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study
Pavan K. Bendapudi et al.
LANCET HAEMATOLOGY (2017)
Thrombotic thrombocytopenic purpura
Johanna A. Kremer Hovinga et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Flora Peyvandi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
John A. Kellum et al.
CRITICAL CARE (2013)
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center
Antoine Froissart et al.
CRITICAL CARE MEDICINE (2012)
How I treat patients with thrombotic thrombocytopenic purpura: 2010
James N. George
BLOOD (2010)
Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience
Paul Coppo et al.
PLOS ONE (2010)
Estimating the capacity for improvement in risk prediction with a marker
Wen Gu et al.
BIOSTATISTICS (2009)
Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs
Chaya S. Moskowitz et al.
CLINICAL TRIALS (2006)
Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement
P Coppo et al.
MEDICINE (2004)
Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias
SL Allford et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
GG Levy et al.
NATURE (2001)
Share Paper
